Recombinetics

Recombinetics

Recombinetics

Recombinetics is a global leader in proprietary gene repair and gene-editing technology.
Founded
2008
Raised
$51.8M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$34,000,000
Venture capital (Series A) - 2018
$11,000,000
Venture capital - 2016
Team Size
10+
Employees
$34,000,000 Venture capital (Series A)
FinSMEs

Biotech Company Recombinetics Closes $34M Series A

Science
$11,000,000 Venture capital
businesswire

Recombinetics Oversubscribes $10 Million Financing Round for Common Stock; Engages Capitol Peak Asset Management | Busin...

$630,000 Venture capital
Twin Cities Business , sec

Recombinetics Secures $630K In Extension Funding Round

Publishing